ASTERDM Aster DM Healthcare Q1 FY26 results (Apr–Jun 2025) and concall
Aster DM Healthcare delivered a strong start to FY26, characterized by significant margin expansion and record-high ARPOB. The quarter marked a recovery in the Kerala cluster and successful rationalization of low-margin scheme businesses in Maharashtra. Management is heavily focused on the upcoming merger with Quality Care India Limited (QCIL), which will create a combined entity with over 10,350 beds and significant procurement synergies.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|---|
| Revenue | 1,086 | 1,050 | 1,000 | 1,078 |
| EBITDA | 217 | 186 | 182 | 202 |
| Net profit | 106 | 64 | 86 | 94 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
